| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +75.00% | -0.44% | +1.35% | -1.79% | -2.16% | — |
| 14d | 4 | +50.00% | +2.04% | +2.40% | -0.36% | -0.07% | — |
| 30d | 4 | +25.00% | +9.73% | +1.72% | +8.01% | +8.95% | — |
| 60d | 4 | +50.00% | +17.71% | +4.98% | +12.72% | +12.45% | — |
| 90d | 4 | +50.00% | +1.94% | +6.69% | -4.75% | -4.86% | — |
| 180d | 4 | +100.00% | -22.37% | +4.93% | -27.30% | -26.87% | — |
| 1y | 4 | +100.00% | -38.67% | +15.62% | -54.30% | -53.93% | — |
| 2y | 4(2 pending) | +100.00% | -90.78% | +34.59% | -125.37% | -125.37% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ELAN ELANCO ANIMAL HEALTH INC | PURCHASEGRANT Stock grant | 12,196 | — | — | 105,588 | May 21, 2026 | May 26, 2026 ↗ | View → |
| ELAN ELANCO ANIMAL HEALTH INC | PURCHASEGRANT Stock grant | 4,678 | — | — | 93,392 | May 21, 2026 | May 26, 2026 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASEGRANT Stock grant | 480,000 | — | — | 480,000 | Feb 1, 2026 | Feb 2, 2026 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASEGRANT Stock grant | 345,000 | — | — | 345,000 | Feb 1, 2026 | Feb 2, 2026 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASEGRANT Stock grant | 1,035,000 | — | — | 1,035,000 | Feb 1, 2026 | Feb 2, 2026 ↗ | View → |
| ELAN ELANCO ANIMAL HEALTH INC | PURCHASEGRANT Stock grant | 10,314 | — | — | 88,714 | Nov 28, 2025 | Dec 2, 2025 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASEGRANT Stock grant | 825,000 | — | — | 825,000 | Jan 25, 2025 | Jan 28, 2025 ↗ | View → |
| ELAN ELANCO ANIMAL HEALTH INC | PURCHASEGRANT Stock grant | 18,169 | — | — | 78,400 | Nov 29, 2024 | Dec 3, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | SALE Chief Executive Officer | 60,046 | $4.22 | $253.5K | 808,921 | Sep 13, 2024 | Sep 16, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | SALE Chief Executive Officer | 28,611 | $4.47 | $128.0K | 868,967 | Sep 12, 2024 | Sep 16, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | SALE Chief Executive Officer | 188,060 | — | — | 0 | Sep 11, 2024 | Sep 13, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASE Chief Executive Officer | 188,060 | — | — | 897,578 | Sep 11, 2024 | Sep 13, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | SALE Chief Executive Officer | 92,273 | $3.39 | $313.1K | 709,518 | Jun 26, 2024 | Jun 27, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | SALE Chief Executive Officer | 40,712 | $3.69 | $150.4K | 801,791 | Jun 25, 2024 | Jun 27, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASE Chief Executive Officer | 282,090 | — | — | 188,060 | Jun 21, 2024 | Jun 25, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASE Chief Executive Officer | 282,090 | — | — | 842,503 | Jun 21, 2024 | Jun 25, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASEGRANT Stock grant | 850,000 | — | — | 850,000 | Jan 25, 2024 | Jan 26, 2024 ↗ | View → |
| ELAN ELANCO ANIMAL HEALTH INC | PURCHASEGRANT Stock grant | 20,374 | — | — | 60,231 | Nov 30, 2023 | Dec 4, 2023 ↗ | View → |
| ELAN ELANCO ANIMAL HEALTH INC | PURCHASEGRANT Stock grant | 18,649 | — | — | 39,857 | Nov 30, 2022 | Dec 2, 2022 ↗ | View → |
| ELAN ELANCO ANIMAL HEALTH INC | PURCHASEGRANT Stock grant | 7,307 | — | — | 21,208 | Nov 30, 2021 | Dec 2, 2021 ↗ | View → |
| ELAN ELANCO ANIMAL HEALTH INC | PURCHASEGRANT Stock grant | 5,885 | — | — | 13,901 | Nov 30, 2020 | Dec 2, 2020 ↗ | View → |